Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
about
Current understanding of interactions between nanoparticles and the immune systemSupramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble DrugsCytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.Designing polymers with sugar-based advantages for bioactive delivery applicationsPast and future evolution in colloidal drug delivery systems.Surface-engineered dendrimers: a solution for toxicity issues.Toxicity of therapeutic nanoparticles.Probing the kinome in real time with fluorescent peptides.Influence of dendrimers on red blood cells.Receptor-based targeting of therapeutics.Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.A preliminary study for novel use of two Mg alloys (WE43 and Mg3Gd).Recent perspectives on the delivery of biologics to back of the eye.Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges.Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates.Doxorubicin and chloroquine coencapsulated liposomes: preparation and improved cytotoxicity on human breast cancer cells.Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.Studying complexes between PPI dendrimers and Mant-ATP.Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.Assessing toxicity of polyamidoamine dendrimers by neuronal signaling functions.Nanoreactors for green catalysis.Tailoring uptake and release of ATP by dendritic glycopolymer/PNIPAAm hydrogel hybrids: first approaches towards multicompartment release systemsGenotoxicity of poly(propylene imine) dendrimersThe biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrierIn vivo toxicity of poly(propyleneimine) dendrimersApplication of Dendrimers for the Treatment of Infectious Diseases
P2860
Q26345204-8EF3045B-1B69-4782-9129-7FAD45B386D9Q26777831-EECCF090-0090-4536-91C9-AA0CEC2EBCDAQ31122095-27D084D3-6AAB-442A-81F4-007F93CFFB0EQ33740696-498B6895-402F-4441-B5E3-CBCF931242AAQ33995843-DE2F06C0-BD32-4C3C-A8F8-17BFD7A4BBA5Q35997103-CE3E448A-8F30-4A46-82E4-622A9C91EFB6Q36307576-18024C7E-E235-4934-9F0B-2072A65608ABQ37039030-E14B2707-7B54-4241-8D4C-332664112676Q37372870-16BEA8A0-C8D7-4B77-9312-2986E16E3171Q37385444-2B5C1F4A-61F0-4840-B8BD-801428827701Q37942751-17096022-3FAF-453D-A142-8333AF35DCF8Q37956522-59BFB1DF-F14E-4B16-864B-6EB473A11EA8Q38084739-BF3633AF-5101-4537-8BE3-B60F1A148F47Q38112504-28A8AFB7-50A4-44FD-9797-A75067B40987Q38292341-8D915BB9-1651-4699-A3F6-679429855DF9Q38767149-F0CC7A2F-4381-4644-9A5E-AC6CB5135F4DQ38787003-6C8A1FF7-2000-4B72-8677-6DFCFDAB484BQ38940171-ADEDFB29-133F-40CD-8F2A-9B09A1BCF8A8Q38983708-BD50F479-25A8-439C-B38A-DBEA2B67405DQ39018790-24EBE4A9-D551-4D57-BCE1-BF4B8F5EF000Q39094882-811B8CA2-D79B-4E0D-BA62-D6B8B783E5C2Q39275254-EBE484BF-A950-4DFE-B3FE-69F73970D5EEQ39346210-CEE762C5-72E5-4E85-B94C-195ECC4D2895Q43235591-BDDB4A2F-0ACE-486C-96DC-2CC1F0E16994Q43737928-2BB9CAC0-6B8A-4E35-BAF1-9E5BE3E1C2A4Q47886606-C37F1056-2BC4-43B9-A0A7-D62A870801ECQ49150358-07B413FA-6E59-4F6C-A76F-74570A1CCAA9Q55047295-55B398CE-0C5D-4DCA-A5C1-9CFFA1AF0536Q57363887-DCFA2880-AEFE-4919-B918-673C8A90CDBFQ57777308-714B04FD-44C0-4B25-AC70-1E210A8359DBQ57777403-FD7D46AE-9BD9-4912-976F-0FB294A3B4D0Q57777440-2CD9A5F0-F2BA-486D-B6A7-F0D9D02FC2B5Q58696083-9AD54552-397B-45FE-9315-1B45974A2E17
P2860
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@ast
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@en
type
label
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@ast
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@en
prefLabel
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@ast
Glycoconjugated peptide dendri ...... very of chloroquine phosphate.
@en
P921
P1433
P1476
Glycoconjugated peptide dendri ...... ivery of chloroquine phosphate
@en
P2093
Payal Agrawal
P304
P356
10.1016/J.BIOMATERIALS.2007.04.004
P50
P577
2007-04-06T00:00:00Z